Daniel S. Budnitz

ORCID: 0000-0002-0136-2623
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Poisoning and overdose treatments
  • Pharmaceutical studies and practices
  • Pharmacovigilance and Adverse Drug Reactions
  • Patient Safety and Medication Errors
  • Opioid Use Disorder Treatment
  • Cardiac Arrest and Resuscitation
  • Emergency and Acute Care Studies
  • Respiratory and Cough-Related Research
  • Diabetes Management and Research
  • Atrial Fibrillation Management and Outcomes
  • Pneumonia and Respiratory Infections
  • Antibiotic Use and Resistance
  • Healthcare Decision-Making and Restraints
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Venous Thromboembolism Diagnosis and Management
  • Vaccine Coverage and Hesitancy
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes Treatment and Management
  • Drug-Induced Hepatotoxicity and Protection
  • Medication Adherence and Compliance
  • SARS-CoV-2 and COVID-19 Research
  • Pain Management and Opioid Use
  • COVID-19 epidemiological studies
  • Cardiovascular Syncope and Autonomic Disorders

Johnson & Johnson (United States)
2024

Centers for Disease Control and Prevention
2013-2023

Emory University
2012-2023

United States Public Health Service
2018-2023

National Center for Emerging and Zoonotic Infectious Diseases
2010-2022

Government of the United States of America
2022

CDC Foundation
2021

National Center for Injury Prevention and Control
2005-2019

Prevention Institute
2018

Massachusetts General Hospital
2018

Adverse drug events are important preventable causes of hospitalization in older adults. However, nationally representative data on adverse that result this population have been limited.We used adverse-event from the National Electronic Injury Surveillance System-Cooperative Drug Event project (2007 through 2009) to estimate frequency and rates after emergency department visits for adults assess contribution specific medications, including those identified as high-risk or potentially...

10.1056/nejmsa1103053 article EN New England Journal of Medicine 2011-11-23

Adverse drug events are common and often preventable causes of medical injuries. However, timely, nationally representative information on outpatient adverse is limited.To describe the frequency characteristics that lead to emergency department visits in United States.Active surveillance from January 1, 2004, through December 31, 2005, National Electronic Injury Surveillance System-Cooperative Drug Event project.National estimates numbers, population rates, severity (measured by...

10.1001/jama.296.15.1858 article EN JAMA 2006-10-17

Since 1990, numerous jurisdictions in the United States (US) have reported increases drug poisoning mortality. During same time period, use of opioid analgesics has increased markedly as part more aggressive pain management. This study documented a dramatic increase mortality rates and compared it to sales nationwide.Trend analysis deaths using underlying cause death multiple data from Centers for Disease Control Prevention analgesic US Drug Enforcement Administration.Unintentional on...

10.1002/pds.1276 article EN Pharmacoepidemiology and Drug Safety 2006-07-24

The Beers criteria identify inappropriate use of medications in older adults. number and risk for adverse events from these are unknown.To estimate the emergency department visits involving compared with other medications.Nationally representative, public health surveillance drug a cross-sectional survey outpatient medical visits.National Electronic Injury Surveillance System-Cooperative Adverse Drug Event System, 2004-2005; National Ambulatory Medical Care Survey, 2004; Hospital...

10.7326/0003-4819-147-11-200712040-00006 article EN Annals of Internal Medicine 2007-12-04

<h3>Importance</h3> The Patient Protection and Affordable Care Act of 2010 brought attention to adverse drug events in national patient safety efforts. Updated, detailed, nationally representative data describing can help focus these <h3>Objective</h3> To describe the characteristics emergency department (ED) visits for United States 2013-2014 changes ED since 2005-2006. <h3>Design, Setting, Participants</h3> Active, representative, public health surveillance 58 EDs located participating...

10.1001/jama.2016.16201 article EN JAMA 2016-11-22

Background.Drug-related adverse events are an underappreciated consequence of antibiotic use, and the national magnitude scope these have not been studied. Our objective was to estimate compare numbers rates emergency department (ED) visits for drug-related associated with systemic antibiotics in United States by drug class, individual drug, event type. Methods.We analyzed from National Electronic Injury Surveillance System–Cooperative Adverse Drug Event project (2004–2006) outpatient...

10.1086/591126 article EN Clinical Infectious Diseases 2008-08-11

Dietary supplements, such as herbal or complementary nutritional products and micronutrients (vitamins minerals), are commonly used in the United States, yet national data on adverse effects limited.

10.1056/nejmsa1504267 article EN New England Journal of Medicine 2015-10-14

Nursing home and long-term care facility residents live in congregate settings are often elderly frail, putting them at high risk for infection with SARS-CoV-2, the virus that causes COVID-19, severe COVID-19-associated outcomes; therefore, this population was prioritized early vaccination United States (1). Following rapid distribution administration of mRNA COVID-19 vaccines (Pfizer-BioNTech Moderna) under an Emergency Use Authorization by Food Drug Administration (2), observational...

10.15585/mmwr.mm7034e3 article EN MMWR Morbidity and Mortality Weekly Report 2021-08-18

IMPORTANCE Detailed, nationally representative data describing high-risk populations and circumstances involved in insulin-related hypoglycemia errors (IHEs) can inform approaches to individualizing glycemic targets.OBJECTIVE To describe the US burden, rates, characteristics of emergency department (ED) visits hospitalizations for IHEs.DESIGN, SETTING, AND PARTICIPANTS Nationally public health surveillance adverse drug events among insulin-treated patients seeking ED care (National...

10.1001/jamainternmed.2014.136 article EN JAMA Internal Medicine 2014-03-10

Budnitz, Daniel S.*; Lovegrove, Maribeth C.*; Shehab, Nadine*; Richards, Chesley L.†‡ Author Information

10.1097/01.sa.0000412401.21757.36 article EN Survey of Anesthesiology 2012-03-24

Assessing the scope of acute medication harms to patients should include both therapeutic and nontherapeutic use.

10.1001/jama.2021.13844 article EN JAMA 2021-10-05

In 2011, an estimated 26.8 million US adults used prescription medications for mental illness.To estimate the numbers and rates of adverse drug event (ADE) emergency department (ED) visits involving psychiatric among between January 1, 2009, December 31, 2011.Descriptive analyses active, nationally representative surveillance ADE ED using National Electronic Injury Surveillance System-Cooperative Adverse Drug Event system prescribing during outpatient Ambulatory Medical Care Survey Hospital...

10.1001/jamapsychiatry.2014.436 article EN JAMA Psychiatry 2014-07-09

The objective of our study was to describe trends in US outpatient antibiotic prescriptions from January through May 2020 and compare with previous years (2017-2019).We used data the IQVIA Total Patient Tracker estimate monthly number patients dispensed retail pharmacies 2017 2020. We averaged estimates 2019 defined expected seasonal change as average percent 2017-2019. calculated percentage point volume changes antibiotics exceeding changes. also per month 2017-2019 versus Data were...

10.1093/cid/ciaa1896 article EN public-domain Clinical Infectious Diseases 2020-12-23

Abstract Background Antibiotics are among the most commonly prescribed medications for children; however, at least one-third of pediatric antibiotic prescriptions unnecessary. National data on short-term antibiotic-related harms could inform efforts to reduce overprescribing and supplement interventions that focus long-term benefits reducing resistance. Methods Frequencies rates emergency department (ED) visits adverse drug events (ADEs) in children were estimated using event from Electronic...

10.1093/jpids/piy066 article EN public-domain Journal of the Pediatric Infectious Diseases Society 2018-07-07

Hydroxychloroquine and chloroquine, primarily used to treat autoimmune diseases prevent malaria, received national attention in early March 2020, as potential treatment prophylaxis for coronavirus disease 2019 (COVID-19) (1). On 20, the Food Drug Administration (FDA) issued an emergency use authorization (EUA) chloroquine phosphate hydroxychloroquine sulfate Strategic National Stockpile be by licensed health care providers patients hospitalized with COVID-19 when determine benefit outweighs...

10.15585/mmwr.mm6935a4 article EN MMWR Morbidity and Mortality Weekly Report 2020-09-03

Residents of long-term care facilities (LTCFs) and health personnel (HCP) working in these are at high risk for COVID-19-associated mortality.As March 2021, deaths among LTCF residents HCP have accounted almost one third (approximately 182,000) the United States (1).Accordingly, were prioritized early receipt COVID-19 vaccination targeted on-site through federal Pharmacy Partnership Long-Term Care Program (2).In December 2020, CDC's National Healthcare Safety Network (NHSN) launched modules,...

10.15585/mmwr.mm7030a2 article EN MMWR Morbidity and Mortality Weekly Report 2021-07-29

Adverse drug events in children from cough and cold medications have been identified as a public health issue with clinical policy implications. Nationally representative morbidity data could be useful for targeting age-appropriate safety interventions.To describe emergency department visits adverse children.Emergency attributed to among aged <12 years were nationally stratified probability sample of 63 US departments January 1, 2004, through December 31, 2005.Annually, an estimated 7091...

10.1542/peds.2007-3638 article EN PEDIATRICS 2008-01-29

Dual antiplatelet therapy (DAT) with clopidogrel plus aspirin is a well-established antithrombotic strategy, hemorrhage being the chief adverse event (AE) of concern. Outside clinical trials, few published data describe magnitude and nature hemorrhage-related AEs from DAT.To estimate numbers rates emergency department (ED) visits for (hemorrhage or evaluation potential hemorrhage) DAT in United States put them context those warfarin, we analyzed National Electronic Injury Surveillance...

10.1001/archinternmed.2010.407 article EN Archives of Internal Medicine 2010-11-22

BACKGROUND: Emergency department visits and subsequent hospitalizations of young children after unsupervised ingestions prescription medications are increasing despite widespread use child-resistant packaging caregiver education efforts. Data on the implicated in limited but could help identify prevention priorities intervention strategies. METHODS: We used nationally representative adverse drug event data from National Electronic Injury Surveillance System–Cooperative Adverse Drug Event...

10.1542/peds.2014-0840 article EN PEDIATRICS 2014-09-16

After reports of increasing emergency department (ED) visits for unsupervised pediatric medication exposures in the 2000s, renewed efforts to improve safety packaging and education were initiated. National data on current trends can help further target interventions.We used nationally representative from Electronic Injury Surveillance System-Cooperative Adverse Drug Event project (2004-2013) assess ED children aged <6 years. For 2010 through 2013, dosage form prescription status implicated...

10.1542/peds.2015-2092 article EN PEDIATRICS 2015-09-08

Adverse drug events (ADEs) are an important cause of patient injury. Although most medications prescribed and used in the outpatient setting, prevention efforts focus on inpatient partly because limited data events. We describe evaluate a new system for surveillance ADEs treated hospital emergency departments (EDs).We guidelines evaluating public health systems, developed by Centers Disease Control Prevention, to assess performance National Electronic Injury Surveillance System-Cooperative...

10.1097/mlr.0b013e318041f737 article EN Medical Care 2007-10-01
Coming Soon ...